{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:31:06Z","timestamp":1793370666362,"version":"4.5.0"},"reference-count":97,"publisher":"Pan African Medical Journal","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PAMJ"],"abstract":"<jats:p>Recurrent pregnancy loss (RPL), defined as the loss of two or more clinically recognized pregnancies before 20 weeks of gestation, poses a significant global medical challenge. Affecting up to 5% of couples trying to conceive, its multifactorial causes include genetic, anatomical, immunological, hormonal, and environmental factors. However, 65% of cases remain idiopathic, exacerbating the complexity of diagnosis and treatment. Low- and middle-income countries (LMICs) face additional challenges due to limited diagnostic capacities, socioeconomic disparities, and the burden of infectious diseases. Advancements in diagnostic and treatment technologies offer promise but are often inaccessible in resource-limited settings. This scoping review involved systematic searches in PubMed, Cochrane Library, and other sources for studies published since 2014. Eligible studies focused on the aetiology, diagnosis, and treatment of RPL. A total of 61 studies were included, primarily from high-income countries, with gaps noted in data from LMICs. Findings highlight RPL's multifaceted aetiology, including chromosomal abnormalities, uterine anomalies, thrombophilias, infections, and lifestyle factors. Advanced diagnostic methods such as next-generation sequencing enable personalized management but remain inaccessible in most LMICs. Management strategies range from immunotherapy and anticoagulants to surgical interventions and lifestyle modifications. Despite promising advancements, gaps in evidence and resource disparities persist, particularly in LMICs, where cultural stigmas and limited healthcare access further complicate care delivery. Addressing RPL requires a multidisciplinary approach encompassing diagnostics, treatment, and psychological support. Tailored strategies are essential for LMICs where inadequate healthcare infrastructure and socioeconomic barriers hinder progress. Prioritizing research, equitable access, and collaborative global efforts are vital to improving outcomes for affected couples worldwide.<\/jats:p>","DOI":"10.11604\/pamj.2025.52.109.46376","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T10:06:35Z","timestamp":1768385195000},"source":"Crossref","is-referenced-by-count":2,"title":["Burden, causes, and treatment approaches of recurrent pregnancy loss: a scoping review"],"prefix":"10.11604","author":[{"given":"Alex","family":"Bosire","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02y9nww90","id-type":"ROR","asserted-by":"publisher"}],"name":"Chuo Kikuu cha Nairobi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Kosgei","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02y9nww90","id-type":"ROR","asserted-by":"publisher"}],"name":"Chuo Kikuu cha Nairobi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gathara","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00a0jsq62","id-type":"ROR","asserted-by":"publisher"}],"name":"London School of Hygiene & Tropical Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9741-2092","authenticated-orcid":false,"given":"Moses","family":"Madadi","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02y9nww90","id-type":"ROR","asserted-by":"publisher"}],"name":"Chuo Kikuu cha Nairobi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Osoti","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02y9nww90","id-type":"ROR","asserted-by":"publisher"}],"name":"Chuo Kikuu cha Nairobi"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4870","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Medicine P. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertility and sterility. 2012;98(5):1103-1111. PubMed | Google Scholar","DOI":"10.1016\/j.fertnstert.2012.06.048"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Coccia ME, Rizzello F, Capezzuoli T, Spitaleri M, Riviello C. Recurrent pregnancy losses and gestational age are closely related: an observational cohort study on 759 pregnancy losses. Reprod Sci. 2015;22(5):556-62. PubMed | Google Scholar","DOI":"10.1177\/1933719114553063"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Cueva S, Burks C, McQueen D, Barkoff MS, Stephenson MD. Maternal antithyroid antibodies and euploid miscarriage in women with recurrent early pregnancy loss. Fertil Steril. 2018;110(3):452-458. PubMed | Google Scholar","DOI":"10.1016\/j.fertnstert.2018.04.026"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Kaandorp SP, van Mens TE, Middeldorp S, Hutten BA, Hof MH, van der Post JA et al. Time to conception and time to live birth in women with unexplained recurrent miscarriage. Hum Reprod. 2014;29(6):1146-52. PubMed | Google Scholar","DOI":"10.1093\/humrep\/deu052"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Sugiura-Ogasawara M, Ebara T, Yamada Y, Shoji N, Matsuki T, Kano H et al. Adverse pregnancy and perinatal outcome in patients with recurrent pregnancy loss: Multiple imputation analyses with propensity score adjustment applied to a large-scale birth cohort of the Japan Environment and Children\u00b4s Study. Am J Reprod Immunol. 2019;81(1):e13072. PubMed | Google Scholar","DOI":"10.1111\/aji.13072"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Ali SB, Jeelall Y, Pennell CE, Hart R, McLean-Tooke A, Lucas M. The role of immunological testing and intervention in reproductive medicine: A fertile collaboration. Am J Reprod Immunol. 2018;79(3). PubMed | Google Scholar","DOI":"10.1111\/aji.12784"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Bouet PE, El Hachem H, Monceau E, Gari\u00e9py G, Kadoch IJ, Sylvestre C. Chronic endometritis in women with recurrent pregnancy loss and recurrent implantation failure: prevalence and role of office hysteroscopy and immunohistochemistry in diagnosis. Fertil Steril. 2016;105(1):106-10. PubMed | Google Scholar","DOI":"10.1016\/j.fertnstert.2015.09.025"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"de Jes\u00fas GR, Rodrigues G, de Jes\u00fas NR, Levy RA. Pregnancy morbidity in antiphospholipid syndrome: what is the impact of treatment. Curr Rheumatol Rep. 2014;16(2):403. PubMed | Google Scholar","DOI":"10.1007\/s11926-013-0403-6"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Diejomaoh MF. Recurrent spontaneous miscarriage is still a challenging diagnostic and therapeutic quagmire. Med Princ Pract. 2015;24 Suppl 1(Suppl 1):38-55. PubMed | Google Scholar","DOI":"10.1159\/000365973"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Garrido-Gimenez C, Alijotas-Reig J. Recurrent miscarriage: causes, evaluation and management. Postgrad Med J. 2015;91(1073):151-62. PubMed | Google Scholar","DOI":"10.1136\/postgradmedj-2014-132672"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Gon\u00e7alves C, Feitosa BM, Cavalcante BV, Lima A, de Souza CM, Joventino LB et al. Obesity and recurrent miscarriage: The interconnections between adipose tissue and the immune system. Am J Reprod Immunol. 2023;90(3):e13757. PubMed | Google Scholar","DOI":"10.1111\/aji.13757"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Jaslow CR. Uterine factors. Obstet Gynecol Clin North Am. 2014;41(1):57-86. PubMed | Google Scholar","DOI":"10.1016\/j.ogc.2013.10.002"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Tasadduq R, Ajmal L, Batool F, Zafar T, Babar A, Riasat A et al. Interecurrent pregnancy lossay of immune components and their association with recurrent pregnancy loss. Hum Immunol. 2021;82(3):162-169. PubMed | Google Scholar","DOI":"10.1016\/j.humimm.2021.01.013"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Bisht S, Dad R. Oxidative stress: Major executioner in disease pathology, role in sperm DNA damage and preventive strategies. Front Biosci (Schol Ed). 2017;9(3):420-447. PubMed | Google Scholar","DOI":"10.2741\/s495"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Cornelisse S, Zagers M, Kostova E, Fleischer K, van Wely M, Mastenbroek S. Preimplantation genetic testing for aneuploidies (abnormal number of chromosomes) in in vitro fertilisation. Cochrane Database Syst Rev. 2020;9(9):CD005291. PubMed | Google Scholar","DOI":"10.1002\/14651858.CD005291.pub3"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Pourmasumi S, Ghasemi N, Talebi A, Ghasemzadeh J, Sabeti P. Protective effects of antioxidant supplements on sperm parameters, sperm DNA damage and level of seminal ROS in recurrent pregnancy loss patients: a clinical trial study. Iranian Red Crescent medical journal. 2019;21(11). Google Scholar","DOI":"10.5812\/ircmj.94197"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"McQueen DB, Zhang J, Robins JC. Sperm DNA fragmentation and recurrent pregnancy loss: a systematic review and meta-analysis. Fertil Steril. 2019;112(1):54-60.e3. PubMed | Google Scholar","DOI":"10.1016\/j.fertnstert.2019.03.003"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Esteves SC, Zini A, Coward RM, Evenson DP, Gos\u00e1lvez J, Lewis SEM et al. Sperm DNA fragmentation testing: Summary evidence and clinical practice recommendations. Andrologia. 2021;53(2):e13874. PubMed | Google Scholar","DOI":"10.1111\/and.13874"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Goenka K, More A, Salve M, Shrivastava D. Study of sperm dna fragmentation index in patients from rural areas of wardha region. Indian journal of forensic medicine and toxicology. 2021;15(2):181-187. Google Scholar","DOI":"10.37506\/ijfmt.v15i2.14300"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Bilibio JP, Gama TB, Nascimento ICM, Meireles AJC, de Aguiar ASC, do Nascimento FC et al. Causes of recurrent miscarriage after spontaneous pregnancy and after in vitro fertilization. Am J Reprod Immunol. 2020;83(5):e13226. PubMed | Google Scholar","DOI":"10.1111\/aji.13226"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Blomqvist L, Hellgren M, Strandell A. Acetylsalicylic acid for prevention of pregnancy loss: a randomized trial. Acta Obstet Gynecol Scand. 2018 Nov;97(11):1365-1372. PubMed | Google Scholar","DOI":"10.1111\/aogs.13420"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Morita K, Ono Y, Takeshita T, Sugi T, Fujii T, Yamada H et al. Risk Factors and Outcomes of recurrent pregnancy loss in Japan. J Obstet Gynaecol Res. 2019;45(10):1997-2006. PubMed | Google Scholar","DOI":"10.1111\/jog.14083"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Lee H-M, Lee HJ, Yang KM, Cha SH, Ahn HK, Kim YJ. Etiological evaluation of repeated biochemical pregnancy in infertile couples who have undergone in vitro fertilization. Obstet Gynecol Sci. 2017;60(6):565-570. PubMed | Google Scholar","DOI":"10.5468\/ogs.2017.60.6.565"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Saravelos SH, Regan L. Unexplained recurrent pregnancy loss. Obstet Gynecol Clin North Am. 2014;41(1):157-66.","DOI":"10.1016\/j.ogc.2013.10.008"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Yu N, Kwak-Kim J, Bao S. Unexplained recurrent pregnancy loss: Novel causes and advanced treatment. J Reprod Immunol. 2023;155:103785. PubMed | Google Scholar","DOI":"10.1016\/j.jri.2022.103785"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Ewington LJ, Tewary S, Brosens JJ. New insights into the mechanisms underlying recurrent pregnancy loss. J Obstet Gynaecol Res. 2019;45(2):258-265. PubMed | Google Scholar","DOI":"10.1111\/jog.13837"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Kutteh WH. Novel strategies for the management of recurrent pregnancy loss. Semin Reprod Med. 2015;33(3):161-8. PubMed | Google Scholar","DOI":"10.1055\/s-0035-1552586"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Branch DW, Silver RM. Practical Work-up and Management of recurrent pregnancy loss for the Front-Line Clinician. Clin Obstet Gynecol. 2016;59(3):535-8. PubMed | Google Scholar","DOI":"10.1097\/GRF.0000000000000216"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Deng T, Liao X, Zhu S. Recent Advances in Treatment of Recurrent Spontaneous Abortion. Obstet Gynecol Surv. 2022;77(6):355-366. PubMed | Google Scholar","DOI":"10.1097\/OGX.0000000000001033"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"van Dijk MM, Kolte AM, Limpens J, Kirk E, Quenby S, van Wely M et al. recurrent pregnancy loss: diagnostic workup after two or three pregnancy losses? A systematic review of the literature and meta-analysis. Hum Reprod Update. 2020;26(3):356-367. PubMed | Google Scholar","DOI":"10.1093\/humupd\/dmz048"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Kaiser J, Branch DW. recurrent pregnancy loss: Generally Accepted Causes and Their Management. Clin Obstet Gynecol. 2016;59(3):464-73. PubMed | Google Scholar","DOI":"10.1097\/GRF.0000000000000214"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Checa MA, Bellver J, Bosch E, Espin\u00f3s JJ, Fabregues F, Fontes J et al. Hysteroscopic septum resection and reproductive medicine: A SWOT analysis. Reprod Biomed Online. 2018;37(6):709-715. PubMed | Google Scholar","DOI":"10.1016\/j.rbmo.2018.09.013"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Quenby S, Gallos ID, Dhillon-Smith RK, Podesek M, Stephenson MD, Fisher J et al. Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss. Lancet. 2021;397(10285):1658-1667. PubMed | Google Scholar","DOI":"10.1016\/S0140-6736(21)00682-6"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Van den Berg MM, Vissenberg R, Goddijn M. Recurrent miscarriage clinics. Obstet Gynecol Clin North Am. 2014;41(1):145-55. PubMed | Google Scholar","DOI":"10.1016\/j.ogc.2013.10.010"},{"key":"ref34","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):89. PubMed | Google Scholar"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210. PubMed | Google Scholar","DOI":"10.1186\/s13643-016-0384-4"},{"key":"ref36","unstructured":"EndNote. EndNote 20. 2022 Accessed on June 2, 2022."},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Alecsandru D, Klimczak AM, Garcia Velasco JA, Pirtea P, Franasiak JM. Immunologic causes and thrombophilia in recurrent pregnancy loss. Fertil Steril. 2021;115(3):561-566. PubMed | Google Scholar","DOI":"10.1016\/j.fertnstert.2021.01.017"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Bashiri A, Halper KI, Orvieto R. Recurrent Implantation Failure-update overview on etiology, diagnosis, treatment and future directions. Reprod Biol Endocrinol. 2018;16(1):121. PubMed | Google Scholar","DOI":"10.1186\/s12958-018-0414-2"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Colley E, Hamilton S, Smith P, Morgan NV, Coomarasamy A, Allen S. Potential genetic causes of miscarriage in euploid pregnancies: a systematic review. Hum Reprod Update. 2019;25(4):452-472. PubMed | Google Scholar","DOI":"10.1093\/humupd\/dmz015"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Dimitriadis E, Menkhorst E, Saito S, Kutteh WH, Brosens JJ. Recurrent pregnancy loss. Nat Rev Dis Primers. 2020;6(1):98. PubMed | Google Scholar","DOI":"10.1038\/s41572-020-00228-z"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Grimstad F, Krieg S. Immunogenetic contributions to recurrent pregnancy loss. J Assist Reprod Genet. 2016;33(7):833-47. PubMed | Google Scholar","DOI":"10.1007\/s10815-016-0720-6"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Gu C, Gong H, Zhang Z, Yang Z, Ma Y. Association of interleukin-10 gene promoter polymorphisms with recurrent pregnancy loss: a meta-analysis. J Assist Reprod Genet. 2016;33(7):907-917. PubMed | Google Scholar","DOI":"10.1007\/s10815-016-0699-z"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Khalife D, Ghazeeri G, Kutteh W. Review of current guidelines for recurrent pregnancy loss: new strategies for optimal evaluation of women who may be superfertile. Semin Perinatol. 2019;43(2):105-115. PubMed | Google Scholar","DOI":"10.1053\/j.semperi.2018.12.008"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Rasmark Roepke E, Hellgren M, Hjertberg R, Blomqvist L, Matthiesen L, Henic E et al. Treatment efficacy for idiopathic recurrent pregnancy loss - a systematic review and meta-analyses. Acta Obstet Gynecol Scand. 2018;97(8):921-941. PubMed | Google Scholar","DOI":"10.1111\/aogs.13352"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Shahine L, Lathi R. Recurrent pregnancy loss: evaluation and treatment. Obstet Gynecol Clin North Am. 2015;42(1):117-34. PubMed | Google Scholar","DOI":"10.1016\/j.ogc.2014.10.002"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Wong LF, Porter TF, Scott JR. Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev. 2014;2014(10):Cd000112. PubMed | Google Scholar","DOI":"10.1002\/14651858.CD000112.pub3"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Ahmadi M, Aghdam SA, Nouri M, Babaloo Z, Farzadi L, Ghasemzadeh A et al. Intravenous immunoglobulin (IVIG) treatment modulates peripheral blood Th17 and regulatory T cells in recurrent miscarriage patients: Non randomized, open-label clinical trial. Immunol Lett. 2017;192:12-19. PubMed | Google Scholar","DOI":"10.1016\/j.imlet.2017.10.003"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Bao SH, Sheng SL, Liao H, Zhou Q, Frempong ST, Tu WY. Use of D-dimer measurement to guide anticoagulant treatment in recurrent pregnancy loss associated with antiphospholipid syndrome. Am J Reprod Immunol. 2017;78(6). PubMed | Google Scholar","DOI":"10.1111\/aji.12770"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Christiansen OB, Larsen EC, Egerup P, Lunoee L, Egestad L, Nielsen HS. Intravenous immunoglobulin treatment for secondary recurrent miscarriage: a randomised, double-blind, placebo-controlled trial. Bjog. 2015;122(4):500-8. PubMed | Google Scholar","DOI":"10.1111\/1471-0528.13192"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Gao HY, Tao EX, Wang Y, Yue QA, Ren CE, Yan LF. Immunomodulatory and clinical effects of the \u2018tiaomian III decoction\u00b4 in patients with blood blocking antibody deficiency and recurrent spontaneous abortion. Genet Mol Res. 2015;14(2):3421-5. PubMed | Google Scholar","DOI":"10.4238\/2015.April.15.5"},{"key":"ref51","unstructured":"Ghasemi N, Jahaninejad T, Mostafavi MS, Aflatoonian A. Effectiveness of aspirin compare with heparin plus aspirin in recurrent pregnancy loss treatment: a quasi experimental study. Iranian journal of reproductive medicine. 2014;12(1):73-76. PubMed | Google Scholar"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Gomaa MF, Elkholy AG, El-Said MM, Abdel-Salam NE. Combined oral prednisolone and heparin versus heparin: the effect on peripheral NK cells and clinical outcome in patients with unexplained recurrent miscarriage. A double-blind placebo randomized controlled trial. Arch Gynecol Obstet. 2014;290(4):757-62. PubMed | Google Scholar","DOI":"10.1007\/s00404-014-3262-0"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Jorgensen M, Baek R, Sloth J, Varming K, Christiansen O, Ditlevsen N et al. Treatment with intravenous immunoglobulin increases the level of small EVs in plasma of pregnant women with recurrent pregnancy loss. Journal of reproductive immunology. 2020;140:103128. PubMed | Google Scholar","DOI":"10.1016\/j.jri.2020.103128"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Li J, Gu Y, Zhang S, Ju B, Wang J. Effect of Prepregnancy Lymphocyte Active Immunotherapy on Unexplained Recurrent Miscarriage, Pregnancy Success Rate, and Maternal-Infant Outcome. Biomed Res Int. 2021;2021:7878752. PubMed | Google Scholar","DOI":"10.1155\/2021\/7878752"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"McQueen DB, Bernardi LA, Stephenson MD. Chronic endometritis in women with recurrent early pregnancy loss and\/or fetal demise. Fertil Steril. 2014;101(4):1026-30. PubMed | Google Scholar","DOI":"10.1016\/j.fertnstert.2013.12.031"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Meng L, Lin J, Chen L, Wang Z, Liu M, Liu Y et al. Effectiveness and potential mechanisms of intralipid in treating unexplained recurrent spontaneous abortion. Arch Gynecol Obstet. 2016;294(1):29-39. PubMed | Google Scholar","DOI":"10.1007\/s00404-015-3922-8"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Kirovakov Z, Konova E, Hinkova N, Markova S, Penchev P. Immunological Risk Factors in recurrent pregnancy loss in Patients With Hereditary Thrombophilia. Cureus. 2024;16(3):e56555. PubMed | Google Scholar","DOI":"10.7759\/cureus.56555"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Cao C, Bai S, Zhang J, Sun X, Meng A, Chen H. Understanding recurrent pregnancy loss: recent advances on its etiology, clinical diagnosis, and management. Med Rev. 2022;2(6):570-589. PubMed | Google Scholar","DOI":"10.1515\/mr-2022-0030"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"Zhou W-J, Yang H-L, Mei J, Chang K-K, Lu H, Lai ZZ et al. Fructose-1,6-bisphosphate prevents pregnancy loss by inducing decidual COX-2+ macrophage differentiation. Sci Adv. 2022;8(8):eabj2488. PubMed | Google Scholar","DOI":"10.1126\/sciadv.abj2488"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Ahmadi M, Ghaebi M, Abdolmohammadi-Vahid S, Abbaspour-Aghdam S, Hamdi K, Abdollahi-Fard S et al. NK cell frequency and cytotoxicity in correlation to pregnancy outcome and response to IVIG therapy among women with recurrent pregnancy loss. J Cell Physiol. 2019;234(6):9428-9437. PubMed | Google Scholar","DOI":"10.1002\/jcp.27627"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"Modzelewski J, Kajdy A, Rabijewski M. The role of lymphocytes in fetal development and recurrent pregnancy loss. Ginekol Pol. 2019;90(2):109-113. PubMed | Google Scholar","DOI":"10.5603\/GP.2019.0019"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"Andreoli L, Tincani A. Beyond the \u201csyndrome\u201d: antiphospholipid antibodies as risk factors. Arthritis & rheumatism. 2012;64(2):342-345. PubMed | Google Scholar","DOI":"10.1002\/art.33341"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"Marder W, Littlejohn EA, Somers EC. Pregnancy and autoimmune connective tissue diseases. Best Practice & Research Clinical Rheumatology. 2016;30(1):63-80. PubMed | Google Scholar","DOI":"10.1016\/j.berh.2016.05.002"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"Khamees DA, Al-Ouqaili MTS. Cross-sectional study of chromosomal aberrations and immunologic factors in Iraqi couples with recurrent pregnancy loss. PeerJ. 2022;10:e12801. PubMed | Google Scholar","DOI":"10.7717\/peerj.12801"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"Rasmark Roepke E, Bruno V, Nedstrand E, Boij R, Strid CP, Piccione E et al. Low-molecular-weight-heparin increases Th1- and Th17-associated chemokine levels during pregnancy in women with unexplained recurrent pregnancy loss: a randomised controlled trial. Sci Rep. 2019;9(1):12314. PubMed | Google Scholar","DOI":"10.1038\/s41598-019-48799-6"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Blue NR, Page JM, Silver RM. Genetic abnormalities and pregnancy loss. Semin Perinatol. 2019;43(2):66-73. PubMed | Google Scholar","DOI":"10.1053\/j.semperi.2018.12.002"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"Al-Thuwaynee S. Assessing the efficacy and safety of Sildenafil vs. Nifedipine in improving endometrial blood flow and thickness in women with recurrent first-trimester miscarriage. J Med Life. 2023;16(6):890-894. PubMed | Google Scholar","DOI":"10.25122\/jml-2023-0068"},{"key":"ref68","unstructured":"Gkeka K, Symeonidis EN, Tsampoukas G, Moussa M, Issa H, Kontogianni E et al. Recurrent miscarriage and male factor infertility: diagnostic and therapeutic implications. A narrative review. Cent European J Urol. 2023;76(4):336-346. PubMed | Google Scholar"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"Bai W, Zhang X, Sun S, Wang Q, Li C, Zhang X et al. Effect of low-molecular-weight heparins on anti-Xa peak levels and adverse reactions in Chinese patients with recurrent spontaneous abortion: a single-center, observational study. BMC Pregnancy Childbirth. 2021;21(1):683. PubMed | Google Scholar","DOI":"10.1186\/s12884-021-04161-1"},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"Khan E, Basharat A, Jamil M, Ayub S, Khan M. Preventive role of low-molecular-weight heparin in unexplained recurrent pregnancy loss. South African journal of obstetrics and gynaecology. 2017;23(1):17-19. Google Scholar","DOI":"10.7196\/SAJOG.2017.v23i1.1112"},{"key":"ref71","doi-asserted-by":"crossref","unstructured":"Achilli C, Duran-Retamal M, Saab W, Serhal P, Seshadri S. The role of immunotherapy in in vitro fertilization and recurrent pregnancy loss: a systematic review and meta-analysis. Fertil Steril. 2018;110(6):1089-1100. PubMed | Google Scholar","DOI":"10.1016\/j.fertnstert.2018.07.004"},{"key":"ref72","unstructured":"Skeith L, Carrier M, Kaaja R, Martinelli I, Petroff D, Schleu\u00dfner E et al. A meta-analysis of low-molecular-weight heparin to prevent pregnancy loss in women with inherited thrombophilia. Journal of thrombosis and haemostasis: JTH. 2016;14:157-158. PubMed | Google Scholar"},{"key":"ref73","doi-asserted-by":"crossref","unstructured":"Egerup P, Nielsen H, Andersen A, Christiansen O. Live Birth Rate in Women with recurrent pregnancy loss after In Vitro Fertilization with Concomitant Intravenous Immunoglobulin and Prednisone. Journal of clinical medicine. 2022;11(7). PubMed | Google Scholar","DOI":"10.3390\/jcm11071894"},{"key":"ref74","doi-asserted-by":"crossref","unstructured":"Lucas ES, Dyer NP, Murakami K, Lee YH, Chan YW, Grimaldi G et al. Loss of Endometrial Plasticity in recurrent pregnancy loss. Stem Cells. 2016;34(2):346-56. PubMed | Google Scholar","DOI":"10.1002\/stem.2222"},{"key":"ref75","doi-asserted-by":"crossref","unstructured":"Whelan A, Burks C, Stephenson MD. Pregnancy Outcomes in Women With a History of Recurrent Early Pregnancy Loss and a Septate Uterus, With and Without Hysteroscopic Metroplasty. Obstet Gynecol. 2020;136(2):417-419. PubMed | Google Scholar","DOI":"10.1097\/AOG.0000000000003953"},{"key":"ref76","doi-asserted-by":"crossref","unstructured":"Al-Husban N, Odeh O, AlRamahi M, Qadri S, Al-Husban H. Fertility-enhancing hysteroscopic surgery; multi-center retrospective cohort study of reproductive outcome. BMC Womens Health. 2023;23(1):459. PubMed | Google Scholar","DOI":"10.1186\/s12905-023-02562-2"},{"key":"ref77","doi-asserted-by":"crossref","unstructured":"Sheikhansari G, Pourmoghadam Z, Danaii S, Mehdizadeh A, Yousefi M. Etiology and management of recurrent implantation failure: A focus on intra-uterine PBMC-therapy for RIF. J Reprod Immunol. 2020;139:103121. PubMed | Google Scholar","DOI":"10.1016\/j.jri.2020.103121"},{"key":"ref78","doi-asserted-by":"crossref","unstructured":"Bosteels J, Kasius J, Weyers S, Broekmans FJ, Mol BWJ, D\u00b4Hooghe TM. Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities. Cochrane Database Syst Rev. 2013;(1):CD009461. Google Scholar","DOI":"10.1002\/14651858.CD009461.pub2"},{"key":"ref79","doi-asserted-by":"crossref","unstructured":"Leng T, Li X, Zhang H. Levothyroxine treatment for subclinical hypothyroidism improves the rate of live births in pregnant women with recurrent pregnancy loss: a randomized clinical trial. Gynecol Endocrinol. 2022;38(6):488-494. PubMed | Google Scholar","DOI":"10.1080\/09513590.2022.2063831"},{"key":"ref80","doi-asserted-by":"crossref","unstructured":"Yoshihara H, Sugiura-Ogasawara M, Goto S, Kitaori T. Levothyroxine and subclinical hypothyroidism in patients with recurrent pregnancy loss. Am J Reprod Immunol. 2021;85(3):e13341. PubMed | Google Scholar","DOI":"10.1111\/aji.13341"},{"key":"ref81","doi-asserted-by":"crossref","unstructured":"McQueen DB, Perfetto CO, Hazard FK, Lathi RB. Pregnancy outcomes in women with chronic endometritis and recurrent pregnancy loss. Fertil Steril. 2015 Oct;104(4):927-931. PubMed | Google Scholar","DOI":"10.1016\/j.fertnstert.2015.06.044"},{"key":"ref82","doi-asserted-by":"crossref","unstructured":"Pirtea P, Cicinelli E, De Nola R, de Ziegler D, Ayoubi JM. Endometrial causes of recurrent pregnancy losses: endometriosis, adenomyosis, and chronic endometritis. Fertil Steril. 2021;115(3):546-560. PubMed | Google Scholar","DOI":"10.1016\/j.fertnstert.2020.12.010"},{"key":"ref83","unstructured":"Habibi M, Zavareh Z, Abbasi B, Esmaeili V, Shahverdi A, Gilani M et al. Alpha-Lipoic Acid Supplementation for Male Partner of Couples with recurrent pregnancy loss: a Post hoc analysis in Clinical Trial. International journal of fertility and sterility. 2023;17(1):67-74. PubMed | Google Scholar"},{"key":"ref84","doi-asserted-by":"crossref","unstructured":"Eisenberg ML, Sapra KJ, Kim SD, Chen Z, Buck Louis GM. Semen quality and pregnancy loss in a contemporary cohort of couples recruited before conception: data from the Longitudinal Investigation of Fertility and the Environment (LIFE) Study. Fertil Steril. 2017;108(4):613-619. PubMed | Google Scholar","DOI":"10.1016\/j.fertnstert.2017.07.008"},{"key":"ref85","doi-asserted-by":"crossref","unstructured":"Zeyneloglu HB, Onalan G. Remedies for recurrent implantation failure. Semin Reprod Med. 2014;32(4):297-305. PubMed | Google Scholar","DOI":"10.1055\/s-0034-1375182"},{"key":"ref86","doi-asserted-by":"crossref","unstructured":"Coughlan C, Ledger W, Wang Q, Liu F, Demirol A, Gurgan T et al. Recurrent implantation failure: definition and management. Reprod Biomed Online. 2014;28(1):14-38. PubMed | Google Scholar","DOI":"10.1016\/j.rbmo.2013.08.011"},{"key":"ref87","unstructured":"Cohen BM, Machupalli S. Use of Gammaglobulin to Lower Elevated Natural Killer Cells in Patients with Recurrent Miscarriage. J Reprod Med. 2015;60(7-8):294-300. PubMed | Google Scholar"},{"key":"ref88","doi-asserted-by":"crossref","unstructured":"Yamada H, Deguchi M, Saito S, Takeshita T, Mitsui M, Saito T et al. Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: a double-blind, randomised, placebo-controlled trial. EClinicalMedicine. 2022;50:101527. PubMed | Google Scholar","DOI":"10.1016\/j.eclinm.2022.101527"},{"key":"ref89","doi-asserted-by":"crossref","unstructured":"Liu J, Li M, Fu J, Yuan G, Li N, Fu Yet al. Tacrolimus improved the pregnancy outcomes of patients with refractory recurrent spontaneous abortion and immune bias disorders: a randomized controlled trial. Eur J Clin Pharmacol. 2023;79(5):627-634. PubMed | Google Scholar","DOI":"10.1007\/s00228-023-03473-9"},{"key":"ref90","doi-asserted-by":"crossref","unstructured":"Sung N, Han AR, Park CW, Park DW, Park JC, Kim NYet al. Intravenous immunoglobulin G in women with reproductive failure: The Korean Society for Reproductive Immunology practice guidelines. Clin Exp Reprod Med. 2017;44(1):1-7. PubMed | Google Scholar","DOI":"10.5653\/cerm.2017.44.1.1"},{"key":"ref91","doi-asserted-by":"crossref","unstructured":"Huang C, Xiang Z, Zhang Y, Tan DS, Yip CK, Liu Z et al. Using Deep Learning in a Monocentric Study to Characterize Maternal Immune Environment for Predicting Pregnancy Outcomes in the Recurrent Reproductive Failure Patients. Front Immunol. 2021;12:642167. PubMed | Google Scholar","DOI":"10.3389\/fimmu.2021.642167"},{"key":"ref92","doi-asserted-by":"crossref","unstructured":"Schleussner E, Kamin G, Seliger G, Rogenhofer N, Ebner S, Toth B et al. Low-molecular-weight heparin for women with unexplained recurrent pregnancy loss: a multicenter trial with a minimization randomization scheme. Annals of internal medicine. 2015;162(9):601-609. PubMed | Google Scholar","DOI":"10.7326\/M14-2062"},{"key":"ref93","doi-asserted-by":"crossref","unstructured":"Nazari L, Salehpour S, Hosseini S, Sheibani S, Hosseinirad H. The Effects of Autologous Platelet-Rich Plasma on Pregnancy Outcomes in Repeated Implantation Failure Patients Undergoing Frozen Embryo Transfer: A Randomized Controlled Trial. Reprod Sci. 2022;29(3):993-1000. PubMed | Google Scholar","DOI":"10.1007\/s43032-021-00669-1"},{"key":"ref94","doi-asserted-by":"crossref","unstructured":"Wojcieszek AM, Shepherd E, Middleton P, Lassi ZS, Wilson T, Murphy MM et al. Care prior to and during subsequent pregnancies following stillbirth for improving outcomes. Cochrane Database Syst Rev. 2018;12(12):CD012203. PubMed | Google Scholar","DOI":"10.1002\/14651858.CD012203.pub2"},{"key":"ref95","doi-asserted-by":"crossref","unstructured":"Hennessy M, Dennehy R, Meaney S, Linehan L, Devane D, Rice R et al. Clinical practice guidelines for recurrent miscarriage in high-income countries: a systematic review. Reprod Biomed Online. 2021;42(6):1146-1171. PubMed | Google Scholar","DOI":"10.1016\/j.rbmo.2021.02.014"},{"key":"ref96","doi-asserted-by":"crossref","unstructured":"Christiansen OB, Kolte AM, Krog MC, Nielsen HS, Egerup P. Treatment with intravenous immunoglobulin in patients with recurrent pregnancy loss: An update. J Reprod Immunol. 2019;133:37-42. PubMed | Google Scholar","DOI":"10.1016\/j.jri.2019.06.001"}],"container-title":["Pan African Medical Journal"],"original-title":[],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T10:06:55Z","timestamp":1768385215000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.panafrican-med-journal.com\/content\/article\/52\/109\/full\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":97,"URL":"https:\/\/doi.org\/10.11604\/pamj.2025.52.109.46376","relation":{},"ISSN":["1937-8688"],"issn-type":[{"value":"1937-8688","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]}}}